Cerqueira-Silva, Thiago http://orcid.org/0000-0003-4534-2509
de Araujo Oliveira, Vinicius http://orcid.org/0000-0001-7858-9650
Paixão, Enny S. http://orcid.org/0000-0002-4797-908X
Júnior, Juracy Bertoldo
Penna, Gerson O. http://orcid.org/0000-0001-8967-536X
Werneck, Guilherme L. http://orcid.org/0000-0003-1169-1436
Pearce, Neil
Barreto, Maurício L. http://orcid.org/0000-0002-0215-4930
Boaventura, Viviane S. http://orcid.org/0000-0002-7241-6844
Barral-Netto, Manoel
Article History
Received: 31 March 2022
Accepted: 4 July 2022
First Online: 18 July 2022
Competing interests
: M.B.-N. reports grants from the <i>Fazer o bem faz bem</i> program from JBS S.A. V.dA.O., V.B., M.L.B., and M.B.-N. are employees of Fiocruz, a federal public institution, which manufactures Vaxzevria in Brazil, through a full technology transfer agreement with AstraZeneca. Fiocruz allocates all its manufactured products to the Ministry of Health for public health use. The remaining authors declare no competing interests.